Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dewar

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Cancer Research|November 19, 2010
Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft modelPhilip J Coates, M Virginia C L Appleyard, Karen Murray, et al.
NPJ Vaccines|August 19, 2025
Stabilization of norovirus GII.3 virus-like particles by rational disulfide engineeringChristopher Warren, Jennifer D Galli, Karin Bystol, et al.
The Lancet. Oncology|September 24, 2013
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsJoanne S Haviland, J Roger Owen, John A Dewar, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Lancet (London, England)|November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialJayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
The Lancet. Oncology|February 29, 2024
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Shane A Johnson, et al.
Cancer Epidemiology|September 12, 2025
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.
The Lancet. Oncology|February 29, 2024
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Ruth Swann, et al.
Nature Food|April 28, 2023
A seafood risk tool for assessing and mitigating chemical and pathogen hazards in the aquaculture supply chainG D Stentiford, E J Peeler, C R Tyler, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Cancer Research|November 19, 2010
Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft modelPhilip J Coates, M Virginia C L Appleyard, Karen Murray, et al.
NPJ Vaccines|August 19, 2025
Stabilization of norovirus GII.3 virus-like particles by rational disulfide engineeringChristopher Warren, Jennifer D Galli, Karin Bystol, et al.
The Lancet. Oncology|September 24, 2013
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsJoanne S Haviland, J Roger Owen, John A Dewar, et al.
The Lancet. Oncology|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Lancet (London, England)|November 15, 2013
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trialJayant S Vaidya, Frederik Wenz, Max Bulsara, et al.
The Lancet. Oncology|February 29, 2024
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Shane A Johnson, et al.
Cancer Epidemiology|September 12, 2025
Chemotherapy use in ovarian cancer patients diagnosed 2012-2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based studyMatthew E Barclay, Sean McPhail, Shane A Johnson, et al.
The Lancet. Oncology|February 29, 2024
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based studySean McPhail, Matthew E Barclay, Ruth Swann, et al.
Nature Food|April 28, 2023
A seafood risk tool for assessing and mitigating chemical and pathogen hazards in the aquaculture supply chainG D Stentiford, E J Peeler, C R Tyler, et al.
Pageof 29